Skip to main content

Table 2 Differences in longitudinal quality of life (QoL) assessed by SF36 and FACT-BMT Form between HID and MSD patients

From: Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation

QoL

HSCT (HID vs. MSD)

Time (months post-HSCT)

β (95% CI) a

P

β (95% CI) a

P

SF-36

 GH

5.46 (0.62, 10.29)

0.027b

0.03 (− 0.15, 0.22)

0.722

 PF

2.83 (− 3.15, 8.82)

0.353

0.30 (0.07, 0.52)

0.011b

 RP

4.06 (− 1.83, 9.94)

0.177

0.82 (0.44, 1.20)

 < 0.001b

 RE

4.83 (− 4.41, 14.08)

0.306

0.33 (-0.10, 0.76)

0.129

 SF

4.21 (− 2.08, 10.51)

0.190

0.68 (0.41, 0.94)

 < 0.001b

 BP

4.06 (− 0.79, 8.91)

0.101

0.09 (− 0.09, 0.27)

0.336

 VT

6.18 (1.37, 11.00)

0.012b

0.12 (− 0.05, 0.29)

0.168

 MH

4.53 (0.38, 8.68)

0.032b

− 0.07 (− 0.20, 0.08)

0.333

FACT-BMT

 PWB

1.49 (0.11, 2.87)

0.034b

0.09 (0.04, 0.14)

 < 0.001b

 SWB

1.29 (0.21, 2.38)

0.020b

− 0.05 (− 0.10, 0.01)

0.099

 EWB

0.47 (− 0.57, 1.50)

0.378

− 0.01 (− 0.04, 0.02)

0.482

 FWB

1.89 (0.52, 3.26)

0.007b

0.02 (− 0.06, 0.10)

0.560

 FACT-G

5.34 (1.72, 8.76)

0.004b

0.05 (− 0.11, 0.20)

0.545

 TOI

2.80 (0.43, 5.18)

0.021b

0.09 (− 0.01, 0.19)

0.095

 FACT-BMT

4.64 (1.09, 8.19)

0.010b

0.03 (− 0.12, 0.17)

0.727

  1. GH general health, PF physical functioning, RP role physical, RE role emotional, SF social functioning, BP bodily pain, VT vitality, MH mental health, PWB physical well-being, FWB functional well-being, SWB social well-being, EWB emotional well-being, FACT-BMT total with BMT module, TOI, FACT-BMT Trial Outcome Index (TOI)
  2. aModel adjusted for age, sex, education, body mass index (BMI), main caregivers, diagnosis, transplantation type, history of aGVHD and cGVHD, and history of infection
  3. bIndicates the statistical significance for the factors